Preventing Esophageal Stent Migration in Esophageal Strictures

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This study aims to assess the efficacy and rate of stent migration in standard of care esophageal stents that are not fixed, compared to those that are fixed with either standard of care OTSC stentfix or standard of care stent placement with suturing in both benign and malignant esophageal strictures.

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT05431738` - Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)	N/A
	Enrolling by invitation	`NCT04007692` - Optimal Endoscopic Suturing Pattern for Esophageal Stent Fixation

NCT number	NCT05081752
Study type	Interventional
Source	NYU Langone Health
Contact
Status	Withdrawn
Phase	N/A
Start date	February 2023
Completion date	September 30, 2025

Preventing Esophageal Stent Migration in Esophageal Strictures

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms